Form D · Other Health Care
Genobank.io Inc
San Francisco, CA · CIK 0001780122
Offering snapshot reported Nov 4, 2019 · SEC filing
- Reported sold
- $215K Offering amount: $500K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 24, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2019 | Initial | $215,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-352450
Simple Agreements for Future Equity convertible or exercisable into Standard Preferred Stock, Safe Preferred Stock or Common Stock, as applicable.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Nov 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Everardo Barojas | Executive |
| Daniel Uribe | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
274 Brannan Street 5th Floor
San Francisco, CA, 94107
San Francisco, CA, 94107